G1 Therapeutics to Present at the Stifel Virtual Healthcare Conference on November 18, 2020

    NEXT STORY
    New Data Show Importance of Vectra® Testing and Biomarkers in Predicting Risk for Cardiovascular Events in Patients with Rheumatoid Arthritis
    PREV STORY
    BioXcel Therapeutics Announces Completion of Pre-NDA Meeting with FDA for BXCL501 for the Acute Treatment of Agitation in Patients with Schizophrenia and Bipolar Disorders
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    SRS Health to Showcase Top-Rated Orthopedic Solutions Suite at 2019 American Academy of Orthopaedic Surgeons (AAOS) Annual Meeting

    author_avatar
    NASDAQ Market News

    BeiGene Presents Initial Clinical Data on PD-1 Antibody BGB-A317 at the 2016 American Society of Clinical Oncology Annual Meeting

    WALTHAM, Mass., June 05, 2016 (GLOBE NEWSWIRE) -- BeiGene, Ltd. (NASDAQ:BGNE), a clinical-stage biopharmaceutical ...

    author_avatar
    NASDAQ Market News

    VBL Therapeutics to Report Third Quarter 2017 Results on November 14

    TEL AVIV, Israel, Nov. 07, 2017 (GLOBE NEWSWIRE) -- VBL Therapeutics (Nasdaq:VBLT), a clinical-stage ...

    author_avatar
    NASDAQ Market News